Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
Beta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multipl...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1799 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849342018025684992 |
|---|---|
| author | V. I. Makolkin D. A. Napalkov |
| author_facet | V. I. Makolkin D. A. Napalkov |
| author_sort | V. I. Makolkin |
| collection | DOAJ |
| description | Beta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multiple clinical indications, including coronary heart disease, arterial hypertension, and chronic heart failure. Due to its super-selectivity it can also be beneficial in patients with diabetes mellitus, chronic obstructive pulmonary disease, and erectile dysfunction. |
| format | Article |
| id | doaj-art-e7a9f5ec70b549fcbc0e8ef4bb3f233c |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 1970-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-e7a9f5ec70b549fcbc0e8ef4bb3f233c2025-08-20T03:43:30Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-01581091161514Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivololV. I. Makolkin0D. A. Napalkov1I.M. Sechenov Moscow Medical Academy. MoscowI.M. Sechenov Moscow Medical Academy. MoscowBeta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multiple clinical indications, including coronary heart disease, arterial hypertension, and chronic heart failure. Due to its super-selectivity it can also be beneficial in patients with diabetes mellitus, chronic obstructive pulmonary disease, and erectile dysfunction.https://cardiovascular.elpub.ru/jour/article/view/1799β-adrenoblockersnebivololcoronary heart diseasearterial hypertensionheart failure |
| spellingShingle | V. I. Makolkin D. A. Napalkov Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol Кардиоваскулярная терапия и профилактика β-adrenoblockers nebivolol coronary heart disease arterial hypertension heart failure |
| title | Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol |
| title_full | Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol |
| title_fullStr | Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol |
| title_full_unstemmed | Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol |
| title_short | Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol |
| title_sort | modern therapeutic potential of super selective β sup 1 sup adrenoblocker nebivolol |
| topic | β-adrenoblockers nebivolol coronary heart disease arterial hypertension heart failure |
| url | https://cardiovascular.elpub.ru/jour/article/view/1799 |
| work_keys_str_mv | AT vimakolkin moderntherapeuticpotentialofsuperselectivebsup1supadrenoblockernebivolol AT danapalkov moderntherapeuticpotentialofsuperselectivebsup1supadrenoblockernebivolol |